FIELD: medicine.
SUBSTANCE: clinico-anamnestic and laboratory-instrumental criteria are determined for the diagnosis of psoriatic arthritis and scores are assigned to them. If the patients are over 40 years old, they get 1 point, skin itching - 1 point, nail psoriasis - 1 point, body mass index (BMI) greater than or equal to 25 kg/m2 - 1 point, erythrocyte sedimentation rate (ESR) greater than or equal to 7 mm/h - 1 point, total cholesterol level over 4.2 mmol/l - 1 point, TNFα cytokine level above 8.1 pg/ml - 1 point, detection of C-597 IL10 genotype - 1 point, hepatomegaly by the results of ultrasound - 1 point. The points obtained are summarized, and with a score of 5 or more, psoriatic arthritis is diagnosed.
EFFECT: method allows to reliably diagnose psoriatic arthritis in patients with psoriasis due to determination of clinico-anamnestic and laboratory-instrumental diagnostic criteria.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR RAPID ASSESSMENT OF AXIAL SKELETON INVOLVEMENT RISK IN EARLY FORMS OF PSORIATIC ARTHRITIS | 2020 |
|
RU2724276C1 |
METHOD FOR ASSESSING THE RISK OF JOINT EROSIONS IN PATIENTS WITH PSORIATIC ARTHRITIS | 2022 |
|
RU2791661C1 |
METHOD FOR DETERMINING PSORIATIC ARTHRITIS ACTIVITY | 2020 |
|
RU2746884C1 |
METHOD FOR DETERMINING INDICATIONS TO BEGINNING OF RECEPTION OF GENETIC ENGINEERING BIOLOGICAL PREPARATIONS WITH INEFFECTIVENESS OF BASIC ANTI-INFLAMMATORY PREPARATIONS IN EARLY FORMS OF PSORIATIC ARTHRITIS | 2020 |
|
RU2731807C1 |
METHOD OF PREDICTING ACHIEVEMENT OF MINIMAL DISEASE ACTIVITY DURING THERAPY IN TREATMENT OF PATIENTS WITH PSORIATIC ARTHRITIS | 2022 |
|
RU2808550C1 |
METHOD FOR ASSESSING THE EFFECTIVENESS OF TREATMENT OF PSORIATIC ARTHRITIS USING OXIDATIVE STRESS PARAMETERS | 2021 |
|
RU2762104C1 |
METHOD FOR PREDICTING THE COURSE OF PSORIATIC ARTHRITIS | 2021 |
|
RU2765111C1 |
METHOD FOR ASSESSING THE EFFECTIVENESS OF TREATMENT OF PSORIATIC ARTHRITIS USING ANTIOXIDANT SYSTEM PARAMETERS | 2021 |
|
RU2762105C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING TYPE 2 PSORIASIS IN POSTMENOPAUSAL WOMEN | 2018 |
|
RU2684287C1 |
DIAGNOSTIC TECHNIQUE FOR PSORIASIS | 2008 |
|
RU2373535C1 |
Authors
Dates
2017-08-30—Published
2016-03-09—Filed